A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn ...

DRESS emphasize personalized care, topical therapies, and selective reintroduction protocols, offering hope for better ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

The U.S. Food and Drug Administration has approved a groundbreaking HIV prevention shot that only needs to be taken twice a year. Medical experts are calling it one of the most significant ...

The U.S. Food and Drug Administration has approved a new HIV prevention medication that's been found to be highly effective.

Juanita Davis with Care4Me services has been educating people in the metro area about HIV prevention and she hopes the drug’s ...

A revolutionary new preventative medicine that protects against the HIV virus has just been approved by the U.S. Food and ...

The Food and Drug Administration has approved a new, first-of-its-kind semiannual HIV prevention medication, Gilead Sciences ...

Colombian billionaire Jaime Gilinski Bacal is open to selling his majority stake in British lender Metro Bank and has ...

The Wistar Institute has launched its HIV Cure and Viral Diseases Center with new lab space on Market Street and a plan to ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.